Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1984 Sep;26(3):419–420. doi: 10.1128/aac.26.3.419

Susceptibilities of 45 clinical isolates of Proteus penneri.

M Fuksa, S Krajden, A Lee
PMCID: PMC176184  PMID: 6508270

Abstract

Patterns of susceptibility of 45 Proteus penneri clinical isolates to 14 antimicrobial agents were evaluated by a macrobroth dilution method. All strains were highly susceptible to ceftizoxime, ceftazidime, moxalactam, cefoxitin, gentamicin, tobramycin, netilmicin, and, with few exceptions, to amikacin, piperacillin, and cefoperazone. Most strains were susceptible to cefotaxime and ceftriaxone. All strains were resistant to cefazolin and cefsulodin.

Full text

PDF
419

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ayers L. W., Jones R. N., Barry A. L., Thornsberry C., Fuchs P. C., Gavan T. L., Gerlach E. H., Sommers H. M. Cefotetan, a new cephamycin: comparison of in vitro antimicrobial activity with other cephems, beta-lactamase stability, and preliminary recommendations for disk diffusion testing. Antimicrob Agents Chemother. 1982 Nov;22(5):859–877. doi: 10.1128/aac.22.5.859. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Hawkey P. M., Pedler S. J., Turner A. Comparative in vitro activity of semisynthetic penicillins against Proteeae. Antimicrob Agents Chemother. 1983 Apr;23(4):619–621. doi: 10.1128/aac.23.4.619. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Hickman F. W., Steigerwalt A. G., Farmer J. J., 3rd, Brenner D. J. Identification of Proteus penneri sp. nov., formerly known as Proteus vulgaris indole negative or as Proteus vulgaris biogroup 1. J Clin Microbiol. 1982 Jun;15(6):1097–1102. doi: 10.1128/jcm.15.6.1097-1102.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Jacobus N. V., Ferreira M. C., Barza M. In vitro activity of azthreonam, a monobactam antibiotic. Antimicrob Agents Chemother. 1982 Nov;22(5):832–838. doi: 10.1128/aac.22.5.832. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Jones R. N., Barry A. L. Antimicrobial activity and other in vitro properties of cefoperazone A, the principal metabolite of cefoperazone sodium. Antimicrob Agents Chemother. 1983 Aug;24(2):293–296. doi: 10.1128/aac.24.2.293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Jones R. N., Fuchs P. C., Sommers H. M., Gavan T. L., Barry A. L., Gerlach E. H. Moxalactam (LY127935), a new semisynthetic 1-oxa-beta-lactam antibiotic with remarkable antimicrobial activity: in vitro comparison with cefamandole and tobramycin. Antimicrob Agents Chemother. 1980 Apr;17(4):750–756. doi: 10.1128/aac.17.4.750. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Kato M., Inoue M., Mitsuhashi S. Antibacterial activities of SM-1652 compared with those of other broad-spectrum cephalosporins. Antimicrob Agents Chemother. 1982 Nov;22(5):721–727. doi: 10.1128/aac.22.5.721. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Kobayashi F., Saino Y., Koshi T., Hattori Y., Nakayama M., Iwasaki A., Mori T., Mitsuhashi S. Antimicrobial and beta-lactamase inhibitory activities of carpetimycins A and B, new carbapenem antibiotics. Antimicrob Agents Chemother. 1982 Apr;21(4):536–544. doi: 10.1128/aac.21.4.536. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Krajden S., Fuksa M., Lizewski W., Barton L., Lee A. Proteus penneri and urinary calculi formation. J Clin Microbiol. 1984 Apr;19(4):541–542. doi: 10.1128/jcm.19.4.541-542.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Muytjens H. L., van der Ros-van de Repe J. Comparative activities of 13 beta-lactam antibiotics. Antimicrob Agents Chemother. 1982 Jun;21(6):925–934. doi: 10.1128/aac.21.6.925. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Neu H. C., Labthavikul P. In vitro activity and beta-lactamase stability of U-63196E, a novel cephalosporin. Antimicrob Agents Chemother. 1983 Sep;24(3):375–382. doi: 10.1128/aac.24.3.375. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Penner J. L., Preston M. A., Hennessy J. N., Barton L. J., Goodbody M. M. Species differences in susceptibilities of Proteeae spp. to six cephalosporins and three aminoglycosides. Antimicrob Agents Chemother. 1982 Aug;22(2):218–221. doi: 10.1128/aac.22.2.218. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Schell R. F., Smith B. R., LeFrock J. L., Francisco M. A. Antimicrobial activity of cefmenoxime compared with those of other cephalosporins. Antimicrob Agents Chemother. 1983 May;23(5):774–777. doi: 10.1128/aac.23.5.774. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Scully B. E., Jules K., Neu H. C. In vitro activity and beta-lactamase stability of cefodizime, an aminothiazolyl iminomethoxy cephalosporin. Antimicrob Agents Chemother. 1983 Jun;23(6):907–913. doi: 10.1128/aac.23.6.907. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Tai M., Fukuoka Y., Yotsuji A., Kumano K., Takahata M., Mikami H., Yasuda T., Saikawa I., Mitsuhashi S. In vitro and in vivo antibacterial activity of T-1982, a new semisynthetic cephamycin antibiotic. Antimicrob Agents Chemother. 1982 Nov;22(5):728–734. doi: 10.1128/aac.22.5.728. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Thornsberry C., Gavan T. L., Sherris J. C., Balows A., Matsen J. M., Sabath L. D., Schoenknecht F., Thrupp L. D., Washington J. A., 2nd Laboratory evaluation of a rapid, automatic susceptibility testing system: report of a collaborative study. Antimicrob Agents Chemother. 1975 Apr;7(4):466–480. doi: 10.1128/aac.7.4.466. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Verbist L. In vitro activity of temocillin (BRL 17421), a novel beta-lactamase-stable penicillin. Antimicrob Agents Chemother. 1982 Jul;22(1):157–161. doi: 10.1128/aac.22.1.157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Wise R., Andrews J. M., Danks G. Comparison of in vitro activity of FCE 22101, a new penem, with those of other beta-lactam antibiotics. Antimicrob Agents Chemother. 1983 Dec;24(6):909–914. doi: 10.1128/aac.24.6.909. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES